Cinemark Holdings, Inc. filings document the public-company disclosures of a global motion picture exhibitor listed on the NYSE under CNK. Its reports include operating results furnished on Form 8-K, Regulation FD disclosures, earnings exhibits and updates on revenue categories, profitability measures, box office performance, concession activity and capital expenditures for its theater circuit.
Other filings cover governance and compensation matters in the definitive proxy statement, common-stock dividends, share repurchase authorization, credit agreement amendments involving Cinemark USA, Inc., and agreements related to convertible senior notes and warrants. The filing record also documents capital structure, board actions, shareholder matters and material events affecting the company’s financing and corporate governance.
Cinemark Holdings, Inc. (CNK) reported third-quarter revenue of $1,059.1 million, compared with $857.5 million in 2025, and net income attributable to Holdings of $122.8 million, versus $49.5 million. Operating income was $206.6 million, compared with $114.4 million; diluted earnings per share were $1.04 versus $0.40. These comparisons show higher sales and earnings than a year earlier.
For the nine months ended September 30, 2026, revenue was $2,788.6 million versus $2,338.7 million, and net income attributable to Holdings was $255.8 million versus $104.1 million. Net cash provided by operating activities was $475.8 million, compared with $248.3 million. Cash and cash equivalents were $555.5 million as of September 30, 2026, compared with $344.3 million as of December 31, 2025. Long-term debt, less current portion, was $1,870.1 million at September 30, 2026. Cinemark paid dividends of $0.09 per common share in the quarter.
Cinemark Holdings, Inc. (CNK) reported third-quarter 2026 revenue of $1,059.1 million, up 23.5% from $857.5 million a year earlier. Net income attributable to Cinemark was $122.8 million, compared with $49.5 million, and diluted earnings per share were $1.04 versus $0.40. Adjusted EBITDA was $267.6 million, compared with $177.6 million; its 25.3% margin expanded 460 basis points year over year. The company described revenue as its highest third-quarter result and Adjusted EBITDA as a third-quarter record.
Attendance was 63.7 million patrons, with admissions revenue of $530.8 million and concession revenue of $413.9 million. Worldwide average ticket price was $8.33 and concession revenue per patron was $6.50. Capital expenditures totaled $70.4 million in the quarter. Cash from operations was $136 million and free cash flow was $66 million for the quarter; cash and cash equivalents stood at $555.5 million as of September 30, 2026.
Cinemark Holdings, Inc. (CNK) reported that the VF Trust returned 38,000 common shares to the issuer on September 25, 2026, at a weighted average sale price of $38.0000 per share. The transaction was made under a Rule 10b5-1 plan. Afterward, the VF Trust held 68,386 shares indirectly; Valmir Fernandes, listed as “Pr - Cinemark International,” reported 37,515 shares held directly.
Cinemark Holdings, Inc. (CNK) has a notice under Rule 144 filed on behalf of officer Valmir Fernandes, as trustee of the VF Trust, covering a proposed sale of 58,000 shares of common stock through Charles Schwab & Co., Inc. at an aggregate market value of $2,040,127. The notice references underlying equity compensation awards from restricted stock lapses and RSAs/PSUs in February 2025 and discloses that 30,000 shares were sold on June 11, 2026 for proceeds of $1,005,150, with 115,911,855 shares of Cinemark common stock outstanding.
Cinemark Holdings, Inc. (CNK) reported that officer Valmir Fernandes, President – Cinemark International, disposed of 20,000 shares of Common Stock on September 11, 2026 in a disposition to the issuer through VF Trust, an indirect ownership vehicle. The reported price of $35.17 per share is a weighted average sale price for the shares, and the filing affirms the transactions were made under a Rule 10b5-1 trading plan. Following this transaction, VF Trust held 106,386 shares indirectly, and Fernandes also held 37,515 shares directly.
Cinemark Holdings, Inc. (CNK) insider Michael Cavalier, EVP–General Counsel, reported an indirect disposition to the issuer of 107,296 shares of common stock on September 1, 2026 through the Cavalier Revocable Trust at a weighted average sale price of $35.02 per share, under a Rule 10b5-1 trading plan. Following this transaction, the trust held 223,385 shares indirectly and Cavalier also held 42,273 shares directly.
Cinemark Holdings, Inc. (CNK) received a Rule 144 notice related to a planned sale of its common stock for the account of Michael Cavalier, an officer, through the Cavalier Revocable Trust. The notice covers 107,296 shares with an aggregate market value of $3,757,078.00, versus 115,911,855 shares outstanding as of September 1, 2026. The shares derive from equity compensation awards, including RSAs and PSUs granted between 2014 and 2025.
Cinemark Holdings, Inc. (CNK) reported that Chief Executive Officer Sean Gamble, through the Joint Revocable Trust of Sean Robert Gamble & Luminita Spetcu, disposed of 7,191 shares of common stock to the issuer on August 31, 2026 at a weighted average sale price of $35.99 per share, under a Rule 10b5-1 trading plan. Following this transaction, the trust held 439,487 shares indirectly, and Gamble also held 219,284 shares directly.
Cinemark Holdings, Inc. (CNK) reported that Chief Executive Officer Sean Gamble, through the Joint Revocable Trust of Sean Robert Gamble & Luminita Spetcu, disposed of 138,884 shares of common stock in a transaction coded as a disposition to the issuer. The reported $38.19 figure is a weighted average sale price for the shares. After this transaction, the trust held 446,678 shares indirectly, and Gamble also held 219,284 shares directly. The filing affirms that the transaction was effected under a Rule 10b5-1 trading plan.
Cinemark Holdings, Inc. (CNK) received a notice that officer Sean Gamble intends to sell up to 146,075 shares of Cinemark common stock under Rule 144 through broker Charles Schwab. The planned sale has an aggregate market value of $5,578,619, versus 115,911,855 shares outstanding. The shares derive from equity compensation awards that lapsed in 2025 and are held in the Joint Revocable Trust of Sean R. Gamble & Luminita Spetcu; sales may occur over various dates.